Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MFAT versus hyaluronic acid for knee osteoarthritis
ISRCTN88966184Phase 2Completed
- Sponsor
- St Catherine Specialty Hospital
- Start
- Aug 2022
- Modality
- Stem Cell Therapies → Cell Therapies
01
Overview
Phase 2, randomised, single-blind trial of microfragmented adipose tissue and Hyalubrix 60 in knee osteoarthritis (OA) (2 arms), sponsored by St Catherine Specialty Hospital. Primary endpoint: Patient-reported knee symptoms, pain, and function. Started Aug 2022; status: completed.
02
Drugs
microfragmented adipose tissueHyalubrix 60
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ISRCTN88966184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN88966184.